Metastatic Colorectal Cancer Clinical Trials Database - Free Access to 467 Studies
Access comprehensive clinical trial information for Metastatic Colorectal Cancer through Pure Global AI's free database. This collection includes 467 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 86 trials are actively recruiting participants.
Research for Metastatic Colorectal Cancer is being conducted in China, United States of America, France and 7+ other countries. Leading sponsors include Amgen and Sun Yat-sen University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Combination Therapy for BRAF-V600E Metastatic CRCm
A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Second-line Treatment of Metastatic Colorectal Cancer
Sacituzumab Govitecan in Metastatic Colorectal Cancer
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
LB-100 (PP2A Inhibitor) and Azenosertib (WEE1 Inhibitor) in Metastatic Colorectal Cancer Patients
Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
Nitazoxanide in Patients With Metastatic Colorectal Cancer
Pure Global AI provides free access to 467 clinical trials studying Metastatic Colorectal Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Amgen, Sun Yat-sen University, Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), among others.